Hosted on MSN3mon
Rare foreign-born CEO says Japan needs immigration to thrivethe head of rice cracker giant Kameda Seika, said he worries his adopted country has lost its edge. "Forty years ago I came to Japan because it was close to number one in GDP... it was booming ...
Numerous Japanese companies are now offering edible ... Sakakibara's company, Marushige Seika, based in Hekinan, Aichi Prefecture, sells dishware products called "E-Tray" for "yakisoba" noodles ...
The company said the lawmaker also likened Meiji Seika Pharma to the Imperial Japanese Army’s Unit 731, which conducted experiments on live Chinese and Russian prisoners to develop biological ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Hosted on MSN27d
Arcturus stock holds $63 target amid Japan production nodOn January 31, Meiji Seika Pharma confirmed the authorization to include domestic production sites in Japan for the vaccine's manufacturing and marketing. The vaccine, Kostaive, which is ...
French biopharmaceutical Osivax, which is developing vaccines to provide broad-spectrum protection against highly mutating ...
gave the green light to CSL and Arcturus’ COVID-19 vaccine ARCT-154 – also known as Lunar-COV19 – which will be commercialised in Japan by partner Meiji Seika Pharma. Japan is the first ...
Lekh Raj Juneja is not your average rice cracker company CEO. Born in India, he came to Japan to study fermentation science and ended up leading a Japanese pharmaceutical firm. Last year he was ...
TOKYO, January 31, 2025--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) announced today that it has received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results